» Articles » PMID: 35361330

Cause, Epidemiology, and Histology of Polyps and Pathways to Colorectal Cancer

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Colorectal cancer is the second leading cause of cancer-associated mortality, with a lifetime risk of approximately 4% to 5%. Colorectal cancer develops from the sequential acquisition of defined genetic mutations in the colonic epithelium. Tumorigenesis from normal tissue to cancer occurs largely through 3 pathways: the chromosomal instability pathway, the microsatellite instability pathway, and the sessile serrated pathway. Colorectal cancer incidence and mortality have decreased by approximately 35% since the beginning of screening programs in the 1990s, although other factors such as use of aspirin for coronary disease prevention and decreased smoking rates may also be important. In this review, we discuss the etiology, epidemiology, and histology of colorectal polyps and cancer.

Citing Articles

Real-world effectiveness and safety of 1L polyethylene glycol and ascorbic acid for bowel preparation in patients aged 80 years or older.

Machlab S, Lorenzo-Zuniga V, Pantaleon M, Sabado F, Arieira C, Perez Arellano E Endosc Int Open. 2025; 13:a25259938.

PMID: 40018074 PMC: 11866040. DOI: 10.1055/a-2525-9938.


Colorectal cancer: local results and significance in Hungary.

Longobardi S J Gastrointest Oncol. 2025; 15(6):2552-2577.

PMID: 39816032 PMC: 11732334. DOI: 10.21037/jgo-24-318.


Diverticulosis and neoplastic lesions in screening colonoscopy: a large, multicenter study.

Fedeli P, Masotti M, Marzano C, Dezi A, Scaccianone G, Martinelli E Ann Gastroenterol. 2025; 38(1):68-71.

PMID: 39802296 PMC: 11724387. DOI: 10.20524/aog.2024.0928.


The Role of miR-486-5p on CSCs Phenotypes in Colorectal Cancer.

Etzi F, Grinan-Lison C, Fenu G, Gonzalez-Titos A, Pisano A, Farace C Cancers (Basel). 2025; 16(24.

PMID: 39766136 PMC: 11674241. DOI: 10.3390/cancers16244237.


Research Progress of in the Treatment of Gastrointestinal Cancer.

Wang L, Ni B, Wang J, Zhou J, Wang J, Jiang J Integr Cancer Ther. 2024; 23:15347354241302049.

PMID: 39610320 PMC: 11605761. DOI: 10.1177/15347354241302049.


References
1.
MORSON B . The evolution of colorectal carcinoma. Clin Radiol. 1984; 35(6):425-31. DOI: 10.1016/s0009-9260(84)80033-1. View

2.
Rex D, Ahnen D, Baron J, Batts K, Burke C, Burt R . Serrated lesions of the colorectum: review and recommendations from an expert panel. Am J Gastroenterol. 2012; 107(9):1315-29. PMC: 3629844. DOI: 10.1038/ajg.2012.161. View

3.
Parsons R, Li G, Longley M, Fang W, Papadopoulos N, Jen J . Hypermutability and mismatch repair deficiency in RER+ tumor cells. Cell. 1993; 75(6):1227-36. DOI: 10.1016/0092-8674(93)90331-j. View

4.
Spring K, Zhao Z, Karamatic R, Walsh M, Whitehall V, Pike T . High prevalence of sessile serrated adenomas with BRAF mutations: a prospective study of patients undergoing colonoscopy. Gastroenterology. 2006; 131(5):1400-7. DOI: 10.1053/j.gastro.2006.08.038. View

5.
Siegel R, Miller K, Sauer A, Fedewa S, Butterly L, Anderson J . Colorectal cancer statistics, 2020. CA Cancer J Clin. 2020; 70(3):145-164. DOI: 10.3322/caac.21601. View